(TTE) TotalEnergies SE - Overview
Stock: Oil, Natural Gas, LNG, Electricity, Biofuels
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.04% |
| Yield on Cost 5y | 16.12% |
| Yield CAGR 5y | 11.84% |
| Payout Consistency | 96.0% |
| Payout Ratio | 59.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.9% |
| Relative Tail Risk | 2.12% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.41 |
| Alpha | 6.50 |
| Character TTM | |
|---|---|
| Beta | 0.075 |
| Beta Downside | 0.477 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.72% |
| CAGR/Max DD | 0.29 |
Description: TTE TotalEnergies SE January 27, 2026
TotalEnergies SE (ticker TTE) is a French-headquartered, multi-energy group operating globally across five business segments: Exploration & Production (oil & natural-gas upstream); Integrated LNG (full LNG value chain plus biogas, hydrogen, and gas trading); Integrated Power (electricity generation, storage, trading and B2B/B2C distribution); Refining & Chemicals (refining, petrochemicals, specialty chemicals, oil trading and marine shipping); and Marketing & Services (petroleum product supply). The company, founded in 1924 and renamed from TOTAL SE in June 2021, serves markets in France, the rest of Europe, North America, Africa and beyond.
According to the Q4 2023 results released in February 2024, TotalEnergies produced ≈ 3.1 million barrels of oil-equivalent per day (≈ 5 % YoY growth) and generated ≈ €30 billion in cash flow, while capex for 2024 is projected at €25–30 billion, with €7 billion earmarked for low-carbon assets (renewables, hydrogen, CCS). Net debt stood at ≈ €42 billion, giving a net-debt-to-EBITDA ratio of ~2.1×, and the company’s carbon intensity fell to ≈ 57 g CO₂e/MWh in its power portfolio, down 12 % year-over-year.
Key drivers for TotalEnergies include sustained high Brent crude prices (≈ $85 / bbl in early 2024), accelerating European LNG demand driven by energy-security policies, and the EU’s Green Deal which incentivizes renewable-generation and hydrogen projects-areas where the firm has increased its capital allocation. For a deeper quantitative assessment, you might explore the ValueRay platform’s detailed valuation models.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 14.16b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.42 > 1.0 |
| NWC/Revenue: 0.60% < 20% (prev 4.03%; Δ -3.42% < -1%) |
| CFO/TA 0.10 > 3% & CFO 29.38b > Net Income 14.16b |
| Net Debt (39.96b) to EBITDA (39.98b): 1.00 < 3 |
| Current Ratio: 1.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.20b) vs 12m ago -6.97% < -2% |
| Gross Margin: 24.91% > 18% (prev 0.28%; Δ 2463 % > 0.5%) |
| Asset Turnover: 63.66% > 50% (prev 71.57%; Δ -7.91% > 0%) |
| Interest Coverage Ratio: 6.80 > 6 (EBITDA TTM 39.98b / Interest Expense TTM 4.02b) |
Altman Z'' 1.87
| A: 0.00 (Total Current Assets 90.93b - Total Current Liabilities 89.83b) / Total Assets 291.96b |
| B: 0.38 (Retained Earnings 112.15b / Total Assets 291.96b) |
| C: 0.09 (EBIT TTM 27.30b / Avg Total Assets 287.98b) |
| D: -0.04 (Book Value of Equity -6.79b / Total Liabilities 174.29b) |
| Altman-Z'' Score: 1.87 = BBB |
Beneish M -2.89
| DSRI: 1.17 (Receivables 19.73b/18.78b, Revenue 183.34b/203.26b) |
| GMI: 1.10 (GM 24.91% / 27.52%) |
| AQI: 1.04 (AQ_t 0.29 / AQ_t-1 0.28) |
| SGI: 0.90 (Revenue 183.34b / 203.26b) |
| TATA: -0.05 (NI 14.16b - CFO 29.38b) / TA 291.96b) |
| Beneish M-Score: -2.89 (Cap -4..+1) = A |
What is the price of TTE shares?
Over the past week, the price has changed by +3.61%, over one month by +10.20%, over three months by +16.05% and over the past year by +16.74%.
Is TTE a buy, sell or hold?
What are the forecasts/targets for the TTE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 62.5 | 1.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 70 | 13.9% |
TTE Fundamental Data Overview February 03, 2026
Market Cap USD = 155.36b (131.06b EUR * 1.1854 EUR.USD)
P/E Trailing = 11.8279
P/E Forward = 10.7527
P/S = 0.7141
P/B = 1.3538
P/EG = 1.734
Revenue TTM = 183.34b USD
EBIT TTM = 27.30b USD
EBITDA TTM = 39.98b USD
Long Term Debt = 49.55b USD (from longTermDebt, last quarter)
Short Term Debt = 13.82b USD (from shortTermDebt, last quarter)
Debt = 63.37b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 39.96b USD (from netDebt column, last quarter)
Enterprise Value = 190.43b USD (155.36b + Debt 63.37b - CCE 28.30b)
Interest Coverage Ratio = 6.80 (Ebit TTM 27.30b / Interest Expense TTM 4.02b)
EV/FCF = 14.74x (Enterprise Value 190.43b / FCF TTM 12.92b)
FCF Yield = 6.78% (FCF TTM 12.92b / Enterprise Value 190.43b)
FCF Margin = 7.05% (FCF TTM 12.92b / Revenue TTM 183.34b)
Net Margin = 7.72% (Net Income TTM 14.16b / Revenue TTM 183.34b)
Gross Margin = 24.91% ((Revenue TTM 183.34b - Cost of Revenue TTM 137.67b) / Revenue TTM)
Gross Margin QoQ = 13.04% (prev 27.44%)
Tobins Q-Ratio = 0.65 (Enterprise Value 190.43b / Total Assets 291.96b)
Interest Expense / Debt = 1.60% (Interest Expense 1.01b / Debt 63.37b)
Taxrate = 39.18% (2.41b / 6.16b)
NOPAT = 16.60b (EBIT 27.30b * (1 - 39.18%))
Current Ratio = 1.01 (Total Current Assets 90.93b / Total Current Liabilities 89.83b)
Debt / Equity = 0.55 (Debt 63.37b / totalStockholderEquity, last quarter 115.28b)
Debt / EBITDA = 1.00 (Net Debt 39.96b / EBITDA 39.98b)
Debt / FCF = 3.09 (Net Debt 39.96b / FCF TTM 12.92b)
Total Stockholder Equity = 116.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.92% (Net Income 14.16b / Total Assets 291.96b)
RoE = 12.11% (Net Income TTM 14.16b / Total Stockholder Equity 116.93b)
RoCE = 16.40% (EBIT 27.30b / Capital Employed (Equity 116.93b + L.T.Debt 49.55b))
RoIC = 9.47% (NOPAT 16.60b / Invested Capital 175.37b)
WACC = 4.68% (E(155.36b)/V(218.73b) * Re(6.19%) + D(63.37b)/V(218.73b) * Rd(1.60%) * (1-Tc(0.39)))
Discount Rate = 6.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.00%
[DCF Debug] Terminal Value 84.23% ; FCFF base≈15.53b ; Y1≈12.87b ; Y5≈9.35b
Fair Price DCF = 114.8 (EV 286.02b - Net Debt 39.96b = Equity 246.07b / Shares 2.14b; r=5.90% [WACC]; 5y FCF grow -20.65% → 2.90% )
EPS Correlation: -76.38 | EPS CAGR: -9.28% | SUE: 0.14 | # QB: 0
Revenue Correlation: -88.78 | Revenue CAGR: -6.11% | SUE: -0.13 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.62 | Chg30d=-0.047 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=6.68 | Chg30d=-0.205 | Revisions Net=-9 | Growth EPS=-5.3% | Growth Revenue=-6.8%